| Metric | Q2 2027 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 2.3M -85.6% | 15.9M +428.8% | 3.0M +22.9% | 2.4M -3.2% | 2.5M |
| R&D | 885.0K +27.0% | 697.0K +66.0% | 420.0K -9.1% | 462.0K -18.7% | 568.0K |
| SG&A | 1.4M -16.6% | 1.7M -34.9% | 2.6M +30.3% | 2.0M +1.3% | 2.0M |
| Operating Income | -2292000 +85.6% | -15917000 -428.8% | -3010000 -22.9% | -2449000 +3.2% | -2529000 |
| EBITDA | -2291000 +3.8% | -2382000 +20.8% | -3008000 -23.0% | -2446000 +3.3% | -2529000 |
| Net Income | -2131000 +86.5% | -15790000 -1240.4% | -1178000 +49.1% | -2315000 -146.8% | -938000 |
| EPS (Basic) | $-0.11 +87.9% | $-0.91 -1200.0% | $-0.07 +50.0% | $-0.14 -133.3% | $-0.06 |
| EPS (Diluted) | $-0.11 +87.9% | $-0.91 -1200.0% | $-0.07 +50.0% | $-0.14 -133.3% | $-0.06 |
| Shares (Diluted) | 20.1M +16.5% | 17.3M +0.1% | 17.3M +1.9% | 16.9M +6.3% | 15.9M |